Group One Trading
ADPT icon

Group One Trading’s Adaptive Biotechnologies ADPT Stock Holding History

Group One Trading’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.2K Sell
5,200
-1,700
-25% -$27.1K ﹤0.01% 4993
2025
Q4 		$112K Sell
6,900
-6,400
-48% -$104K ﹤0.01% 4908
2025
Q3 		$199K Buy
13,300
+9,300
+233% +$113K ﹤0.01% 4669
2025
Q2 		$46.6K Buy
4,000
+2,200
+122% +$20K ﹤0.01% 5636
2025
Q1 		$13.4K Sell
1,800
-7,500
-81% -$57.6K ﹤0.01% 6073
2024
Q4 		$55.8K Buy
9,300
+300
+3% +$1.65K ﹤0.01% 4968
2024
Q3 		$46.1K Sell
9,000
-7,000
-44% -$30.5K ﹤0.01% 4712
2024
Q2 		$57.9K Buy
16,000
+15,000
+1,500% +$47.6K ﹤0.01% 4412
2024
Q1 		$3.21K Sell
1,000
-32,000
-97% -$124K ﹤0.01% 6349
2023
Q4 		$162K Sell
33,000
-7,000
-18% -$31.9K ﹤0.01% 4050
2023
Q3 		$218K Buy
40,000
+38,800
+3,233% +$257K ﹤0.01% 3733
2023
Q2 		$8.05K Sell
1,200
-38,000
-97% -$283K ﹤0.01% 6497
2023
Q1 		$346K Buy
39,200
+39,100
+39,100% +$345K ﹤0.01% 3127
2022
Q4 		$764 Sell
100
-5,300
-98% -$41.2K ﹤0.01% 6889
2022
Q3 		$38K Buy
5,400
+5,000
+1,250% +$47.1K ﹤0.01% 5611
2022
Q2 		$3K Buy
400
+300
+300% +$2.64K ﹤0.01% 7262
2022
Q1 		$1K Sell
100
-5,100
-98% -$80.2K ﹤0.01% 7796
2021
Q4 		$146K Buy
5,200
+3,500
+206% +$107K ﹤0.01% 5395
2021
Q3 		$58K Sell
1,700
-14,400
-89% -$521K ﹤0.01% 6425
2021
Q2 		$658K Buy
16,100
+14,500
+906% +$564K ﹤0.01% 3910
2021
Q1 		$64K Sell
1,600
-20,300
-93% -$1.1M ﹤0.01% 6044
2020
Q4 		$1.29M Sell
21,900
-42,100
-66% -$2.17M ﹤0.01% 2416
2020
Q3 		$3.11M Buy
64,000
+20,800
+48% +$874K 0.01% 1244
2020
Q2 		$2.09M Buy
43,200
+28,600
+196% +$1.04M 0.01% 1439
2020
Q1 		$406K Buy
14,600
+10,700
+274% +$298K ﹤0.01% 2202
2019
Q4 		$117K Buy
3,900
+2,800
+255% +$80.4K ﹤0.01% 3539
2019
Q3 		$34K Buy
+1,100
New +$44.9K ﹤0.01% 4157

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's ADPT Position: Q3 2025 in Review

Group One Trading sold out of Adaptive Biotechnologies (ADPT) in Q3 2025, closing a stake of 887 shares — an estimated $10.8K sold.

Group One Trading first reported a position in ADPT in Q4 2019 and held it in 13 quarters. The position peaked at $296K in Q4 2022. 271 funds tracked by Wall St. Rank hold ADPT as of Q3 2025.

  • Group One Trading reported no remaining Adaptive Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 887 Adaptive Biotechnologies shares in Q3 2025, an estimated $10.8K.
  • Group One Trading first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 13 quarters.
  • Group One Trading's Adaptive Biotechnologies position peaked at $296K in Q4 2022.
  • 271 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.